Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when 4D Molecular Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FDMT alertsDavid is recorded as CEO at 4D Molecular Therapeutics, Inc. (FDMT). David has spoken on 1 investor event across 1 company, most recently for 4D Molecular Therapeutics, Inc. on November 16, 2026. 4D Molecular Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at 4D Molecular Therapeutics, Inc. includes David Kirn (CEO and Board Member), David Kirn, M.D. (CEO), Ashoo Gupta (CFO) and 7 others.
“Okay, so today we're going to be focused on our lead asset 4150, which we think has the potential to create a new treatment paradigm in wet AMD and other neovascular diseases.”
Biotechnology · Healthcare
CEO